Evidence map›Paper›PMID 27690369›Full record

ReviewClinical and experimental immunology2017

DNA methylation alterations in the pathogenesis of lupus.

S H Chen, Q L Lv, L Hu, M J Peng, G H Wang, B Sun

Open access · bronzeAbstract readReview
In one paragraph

Review in Clinical and experimental immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Methylation ofDiagnostics (Basel, Switzerland) · 2022
    Article
  8. Article
  9. The Epigenome in Atherosclerosis.Handbook of experimental pharmacology · 2022
    Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Epigenetics of inflammatory arthritis.Current opinion in rheumatology · 2018
    Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

S H ChenDepartment of Oncology, Changsha Central Hospital, Changsha, China.
Q L LvDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China.
L HuDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China.
M J PengDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China.
G H WangDepartment of Oncology, Changsha Central Hospital, Changsha, China.
B SunDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China.
Central South University · CNChangsha Central Hospital · CNXiangya Hospital Central South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although lupus is, by definition, associated with genetic and immunological factors, its molecular mechanisms remain unclear. The up-to-date research findings point out that various genetic and epigenetic factors, especially gene-specific and site-specific methylation, are believed to contribute to the initiation and development of systemic lupus erythematosus (SLE). This review presents and summarizes the association between abnormal DNA methylation of immune-related cells and lupus-like diseases, as well as the possible mechanisms of immune disorder caused by DNA methylation, aiming at a better understanding of the roles of aberrant DNA methylation in the initiation and development of certain forms of lupus and providing a new insight into promising therapeutic regimens in lupus-like diseases.

Indexed as

AutoimmunityDNA MethylationAnimalsEpigenesis, GeneticGene Expression RegulationHumansLupus Erythematosus, SystemicDNA methylationimmune-related cellslupus-like diseasessystemic lupus erythematosus

Identifiers

PMID27690369
PMCPMC5217979
OpenAlexW2529631355

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.